Unknown

Dataset Information

0

Asparagine and Glutamine Deprivation Alters Ionizing Radiation Response, Migration and Adhesion of a p53null Colorectal Cancer Cell Line.


ABSTRACT: Colorectal cancer (CRC) is the most prominent form of colon cancer for both incidence (38.7 per 100,000 people) and mortality (13.9 per 100,000 people). CRC's poor response to standard therapies is linked to its high heterogeneity and complex genetic background. Dysregulation or depletion of the tumor suppressor p53 is involved in CRC transformation and its capability to escape therapy, with p53null cancer subtypes known, in fact, to have a poor prognosis. In such a context, new therapeutic approaches aimed at reducing CRC proliferation must be investigated. In clinical practice, CRC chemotherapy is often combined with radiation therapy with the aim of blocking the expansion of the tumor mass or removing residual cancer cells, though contemporary targeting of amino acid metabolism has not yet been explored. In the present study, we used the p53null Caco-2 model cell line to evaluate the effect of a possible combination of radiation and L-Asparaginase (L-ASNase), a protein drug that blocks cancer proliferation by impairing asparagine and glutamine extracellular supply. When L-ASNase was administered immediately after IR, we observed a reduced proliferative capability, a delay in DNA-damage response and a reduced capability to adhere and migrate. Our data suggest that a correctly timed combination of X-rays and L-ASNase treatment could represent an advantage in CRC therapy.

SUBMITTER: Guardamagna I 

PROVIDER: S-EPMC9917910 | biostudies-literature | 2023 Feb

REPOSITORIES: biostudies-literature

altmetric image

Publications

Asparagine and Glutamine Deprivation Alters Ionizing Radiation Response, Migration and Adhesion of a p53<sup>null</sup> Colorectal Cancer Cell Line.

Guardamagna Isabella I   Iaria Ombretta O   Lonati Leonardo L   Mentana Alice A   Previtali Andrea A   Uggè Virginia V   Ivaldi Giovanni Battista GB   Liotta Marco M   Tabarelli de Fatis Paola P   Scotti Claudia C   Pessino Greta G   Maggi Maristella M   Baiocco Giorgio G  

International journal of molecular sciences 20230203 3


Colorectal cancer (CRC) is the most prominent form of colon cancer for both incidence (38.7 per 100,000 people) and mortality (13.9 per 100,000 people). CRC's poor response to standard therapies is linked to its high heterogeneity and complex genetic background. Dysregulation or depletion of the tumor suppressor p53 is involved in CRC transformation and its capability to escape therapy, with p53<sup>null</sup> cancer subtypes known, in fact, to have a poor prognosis. In such a context, new thera  ...[more]

Similar Datasets

| S-EPMC6580962 | biostudies-literature
| S-EPMC9576409 | biostudies-literature
| S-EPMC7429491 | biostudies-literature
| S-EPMC5528315 | biostudies-literature
| S-EPMC6713455 | biostudies-literature
| S-EPMC3687028 | biostudies-literature
| S-EPMC9532994 | biostudies-literature
| S-SCDT-EMBOJ-2019-103009 | biostudies-other
| S-EPMC4069168 | biostudies-literature
| S-EPMC3431329 | biostudies-literature